Stress Echocardiography: A Historical Perspective (or, How I Ate My Father)
As happens with any scientific innovation, stress echocardiography completed its life cycle by moving from the status of “promising innovation”, used by a few enthusiastic supporters amid general skepticism, up to the rank of “established technology” accepted by virtually the whole cardiological community (Fig. i) — sometimes even overused, with an embarassing lack of common sense tending to transform the technique into a totem — whose responses, taken out of the overall clinical context, may produce more problems than solutions in patient management. The impressive increase in the amount of editorial space devoted to stress echo in major journals and meetings testifies to its increased acceptance by cardiologists (Fig. 2). Ten years ago, stress echo was a scientific fact without clinical substance: an academic somersault in front of empty seats. At present, the real risk for stress echo is to become a clinical fact without scientific substance: all laboratories do stress echo, but often in the wrong way and/or with inappropriately selected patients.
KeywordsIschemia Amid Adenosine Radionuclide Cardiol
Unable to display preview. Download preview PDF.
- 1.Lewis R (1994) The evolution man - or, how I ate my father. Vintage, New YorkGoogle Scholar
- 2.Tennant R, Wiggers CJ (1935) The effects of coronary occlusion on myocardial contraction. Am J Phys 112: 351 - 361Google Scholar
- 4.Kerber RE, Abboud FM (1973) Echocardiographic detection of regional myocardial infarction. An experimental study. Circulation 47: 997-1005Google Scholar
- 6.Sugishita Y, Koshi S, Matsudo M, Tamura T, Yamaguchi I, Ito I (1984) Dissociation between regional myocardial disfunction and ECG changes during myocardial ischemia induced by exercise in patients with angina pectoris. Am Heart J 1o6: 1 - 8Google Scholar
- 9.Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L’Abbate A (1985) Dipyridamoleechocardiography test in effort angina pectoris. Am J Cardiol 56: 452-456Google Scholar
- 10.Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE (199o) Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 15:1021-1031.Google Scholar
- 11.Zaret BL (1996) Nuclear cardiology. In: Braunwald E (ed) Textbook of heart disease, 5th edn. Saunders, New YorkGoogle Scholar
- 12.Verani M (1994) Should all patients undergo cardiac catheterization after a myocardial infarction? J Nucl Cardiol 1:S 134-146Google Scholar
- 13.Hugenholtz PG (1991) Ischemic heart disease: left ventricular function and coronary heart disease. Chairman’s overview. In: Nitter-Hauge S, Allison D (eds) Cardiac imaging: X-ray, MR, and ultrasound. Excerpta Medica, Amsterdam, International Congress Series, no. 922, Pp 131 - 140Google Scholar
- 15.Falk E (1992) Why do plaques rupture? Circulation [Suppl III]: III30-III42Google Scholar
- 17.Lanza G, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA(1996) A novel site - targeted ultrasonic contrast agent with broad biomedical application. Circulation 95: 3334 - 3340Google Scholar